Natural Killer (NK) CD56Dim and CD56Bright cell phenotypes in peripheral blood associated with Multiple Sclerosis (MS). Recently it has been suggested that NK cell phenotype could be associated with ... cytotoxic…
Multiple Sclerosis (MS) is still a mysterious pathology. A lot of investigation is on course, but it Is hard to get to a solid conclusion/ consensus about how people ... physically to slow down the evolution of their MS…
results, GSNO could be proposed as an innovative prophylactic agent, in order to prevent relapses of inflammation for inflammatory bowel diseases patient in clinical remission. The human gastrointestinal tract ... bowel…
Multiple sclerosis (MS) is an autoimmune demyelinating disease of the central nervous system, usually beginning between 20 and 40 years (predominantly in females). Neurological guidelines consider MS as the most…
Multiple sclerosis (MS) is an autoimmune demyelinating disease of the central nervous system, usually beginning between 20 and 40 years (predominantly in females). Neurological guidelines consider MS as the most…
Multiple sclerosis is characterized by multifocal CNS lesions with perivenular inflammation, demyelination, axonal transection, neuronal degeneration and gliosis. Proinflammatory CD4+ and CD8+ T cells reactive to CNS…
nerve and spinal cord. For a long time, NMO was considered a variant of Multiple Sclerosis (MS). However, recent mounting evidence points to a distinct pathogenesis. An important step ... specificity of 91-100%…
irregular, asymmetric movement patterns and postures due to muscular weakness, spasticity or imbalance in Multiple Sclerosis (MS). The aim was to investigate musculoskeletal disorders and risk factors of low back…
Multiple sclerosis (MS) is a socially important disease, with a high level of acquired disability in a relatively young population. Motor weakness, spasticity, balance and coordination dysfunctions provoke severe…
Multiple Sclerosis (‘MS’) is a chronic neurological disorder characterised by immune-mediated damage to the central nervous system. Ocrelizumab (‘OCR’) is a novel disease-modifying therapy that has shown promising…
time of diagnosis. Peroral fingolimod is an immunomodulating drug, approved for treating multiple sclerosis. Peroral fingolimod, after hepatic metabolization, impairs migration of lymphocytes from lymph nodes…
Introduction: Pain is a key symptom in patients with multiple sclerosis (MS), but the prevalence of pain in MS and its impact on quality of life of the patients ... least one type of pain or unpleasant pain sensation…
Multiple sclerosis (MS) is a socially important disease, with a high level of acquired disability in a relatively young population. Motor weakness, spasticity, balance and coordination dysfunctions provoke severe…
extracellular matrix protein anosmin-1, in both cases through FGFR1. In postmortem samples of multiple sclerosis (MS) patients, FGF-2 is present in areas of active demyelination where the spontaneous ... growth factor…
with autologous haematopoietic stem cell transplantation (AHSCT) is a new and promising approach to multiple sclerosis (MS) treatment. Recently, the rationale of evolution from myeloablative to non-myeloablative (NM)…
Tissue- type plasminogen activator (t-PA) and its inhibitor (PAI-1) in patients with multiple sclerosis. Patients and methods: A pilot study was carried out on a total of twenty ... significant association between the…
Background: Multiple sclerosis (MS) is a chronic and progressive autoimmune disease of the central nervous system that causes motor and sensory impairment and physical disability in patients. This study ... male/female…
most common clinical screen for cognitive impairment. Cognitive impairment is a frequent symptom of multiple sclerosis (MS) and can be difficult to detect in routine evaluation. Although specific screening measures…
Introduction: Multiple sclerosis (MS) is a demyelinating disease of the central nervous system leading to disability, especially in young patients. Acute or chronic lesions of MS within the brainstem ... various…
Multiple sclerosis [M.S] is one of the common autoimmune diseases that effects on central nervous system. It is unpredictable and cause to changes in life style. M.S progresses to inability ... methods. Findings showed…
Multiple sclerosis (MS) and neuro-BehÃ?§etâÂ?Â?s disease (NBD) are two recurrent disorders affecting the central nervous system (CNS) by causing inflammation and irreversible damage. Inaugural clinical symptoms…
Background: Multiple sclerosis (MS), ensuring demyelization, resulting in physical disability, is the most chronic and inflammatory disorder. Because of limited efficacy and adverse side effects of the current…
Background: Multiple sclerosis (MS), ensuring demyelization results in physical disability, is the most chronic and inflammatory disorder. Because of limited efficacy and adverse side effects of the current treatments…
Background and aim: Multiple sclerosis (MS) is a rare inflammatory demyelinating disorder of a nervous system. Good sleep is a very important issue among MS patients. Studies about sleep quality ... With regards to the…
Multiple Sclerosis (MS) is an inflammatory and neurodegenerative disease which is associated with marked brain atrophy. The magnetic resonance imaging (MRI) is a means of predicting subsequent disability. Brain atrophy…
For authors and organisers
Publish, present and keep up with your field
Find the right journal for your paper and submit your manuscript.